详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Jiang, Qian[1] * ; Li, Zongru[2] ; Zhang, Gongli[3] ; Hu, Yu[4] ; Li, Weiming[5] ; Song, Yongping[6] ; Li, Junmin[7] ; Zhou, Li[7] ; Liu, Bingcheng[8] ; Liu, Xiaoli[9] ; Xu, Na[9] ; Chen, Suning[10] ; Liu, Zhenfang[11] ; Zhu, Huanling[12] ; Jin, Jie[13] ; Huang, He[13] ; Qian, Sixuan[14] ; Meng, Li[15] ; Du, Xin[16] ; Zhao, Xielan[17] ; Gao, Sujun[18] ; Liang, Yang[19] ; Hou, Ming[20] ; Wang, Wei[21] ; Chen, Zi[22] ; Niu, Qian[22] ; Men, Lichuang[22] ; Yang, Dajun[23,24] ; Zhai, Yifan[23,24] ; Huang, Xiaojun[2] ;

单位： [1]Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing, Peoples R China [2]Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China [3]Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China [4]Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [5]Huazhong Univ Sci & Technol, Dept Hematol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [6]Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Henan Canc Hosp, Zhengzhou, Peoples R China [7]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China [8]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin, Peoples R China [9]Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China [10]Southern Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Peoples R China [11]Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China [12]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [13]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China [14]Zhejiang Univ, Hematol, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China [15]Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China [16]Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [17]Shenzhen Univ, Div Hematol, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Shenzhen, Peoples R China [18]Cent South Univ, Xiangya Hosp, Changsha, Peoples R China [19]First Hosp Jilin Univ, Changchun, Peoples R China [20]Sun Yat Sen Univ, Canc Ctr, Dept Hematol Oncol, Guangzhou, Peoples R China [21]Shandong Univ, Qilu Hosp, Shandong, Peoples R China [22]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China [23]Guangzhou Healthquest Pharma Co Ltd, Guangzhou, Peoples R China [24]Ascentage Pharma Grp Inc, Rockville, MD USA

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2021]版：

Q1 HEMATOLOGY

最新[2023]版：

Q1 HEMATOLOGY

第一作者：

第一作者单位： [1]Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing, Peoples R China

通讯作者：

通讯机构： [23]Guangzhou Healthquest Pharma Co Ltd, Guangzhou, Peoples R China [24]Ascentage Pharma Grp Inc, Rockville, MD USA

推荐引用方式(GB/T 7714)：

APA：

MLA：

Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

文献详情